Skip to main content
SpringerLink
Log in

Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes

  • Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes
  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hillman A. Cost-effectiveness opportunities for new antibiotics. PharmacoEconomics 1994; 5 Suppl. 2: 40–3.

    Article  PubMed  CAS  Google Scholar 

  2. Davey PG, Malek MM, Parker SE. Pharmacoeconomics of antibacterial treatment. PharmacoEconomics 1992; 1: 409–36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Unit, Bichat Hospital, 46, rue Henri Huchard, 75877, Paris Cedex 18, France

    C. Carbon

Authors
  1. C. Carbon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carbon, C. Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes. Drugs 52 (Suppl 2), 78–79 (1996). https://doi.org/10.2165/00003495-199600522-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600522-00015

Keywords

Search

Navigation